Kinaset Therapeutics

Kinaset Therapeutics intends to develop novel therapies that can positively impact patients with refractory diseases, including severe asthma. Kinaset Therapeutics' innovative leading assets and experienced team are combined with a dedicated group of drug development experts committed to advancing this therapy, utilizing what may be a first-in-class approach to treating severe asthma.